BioSpace News Archive

LeMaitre Vascular, Inc. announced that it is participating in two investor conferences in August.

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that the European Medicines Agency (EMA) issued scientific advice to Emmaus regarding the clinical development pathway for Xyndari™ for the treatment of sickle cell disease.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced the expansion of their renowned Certified Duchenne Care Center Program (CDCCP) with the certification of the clinic at Akron Children’s Hospital (Akron Children’s) in Akron, Ohio.

ProMIS Neurosciences, Inc. (the “Corporation”) (TSX: PMN; OTCQB: ARFXF), today announced the voting results of the Corporation’s annual meeting of shareholders held on July 29, 2020 in Vancouver, British Columbia, Canada (the “Meeting”).

Magnolia Medical announced today that it has been awarded a 3-year agreement with Intalere for the Steripath® Gen2 Initial Specimen Diversion Device® product portfolio.

IDTechEx Research predicts that the market for image recognition AI in medical diagnostics will exceed $3 billion by 2030.

Perrigo Company plc, a leading global provider of Quality, Affordable Self-Care Products, announced that its Board of Directors declared a quarterly dividend of $0.225 per share, payable on September 15, 2020 to shareholders of record on August 28, 2020.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it will host a conference call and webcast on Monday, August 10, 2020 at 1:30 pm PT/4:30 pm ET to report its second quarter 2020 financial results and provide a corporate update.

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today that it will report its second quarter 2020 financial and operating results after the close of U

Cerner Corporation (Nasdaq: CERN) today announced results for the 2020 second quarter that ended June 30, 2020. The quarterly financial results can be viewed on the company’s website at https://investors.cerner.com/financial-releases . Cerner will host an earnings conference call to provide additional detail on the Company’s results and outlook at 3:30 p.m. CT on July 29, 2020. On the call, Cerner will discuss its second quarter 20